$7.06
4.08% yesterday
Nasdaq, Apr 04, 10:00 pm CET
ISIN
US6821431029
Symbol
OMER
Sector
Industry

Omeros Corporation Stock price

$7.06
-0.92 11.53% 1M
+3.29 87.27% 6M
-2.82 28.54% YTD
+3.94 126.28% 1Y
+0.78 12.42% 3Y
-6.82 49.14% 5Y
-16.17 69.61% 10Y
Nasdaq, Closing price Fri, Apr 04 2025
-0.30 4.08%
ISIN
US6821431029
Symbol
OMER
Sector
Industry

Key metrics

Market capitalization $409.93m
Enterprise Value $743.08m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio negative
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-169.26m
Free Cash Flow (TTM) Free Cash Flow $-148.97m
Cash position $90.13m
EPS (TTM) EPS $-2.70
P/E forward negative
P/S forward 115.15
EV/Sales forward 208.73
Short interest 17.15%
Show more

Is Omeros Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Omeros Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Omeros Corporation forecast:

3x Buy
60%
2x Hold
40%

Analyst Opinions

5 Analysts have issued a Omeros Corporation forecast:

Buy
60%
Hold
40%

Financial data from Omeros Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
- -
-
100%
- Direct Costs 0.95 0.95
7% 7%
-
-0.95 -0.95
7% 7%
-
- Selling and Administrative Expenses 49 49
1% 1%
-
- Research and Development Expense 119 119
4% 4%
-
-168 -168
3% 3%
-
- Depreciation and Amortization 0.95 0.95
7% 7%
-
EBIT (Operating Income) EBIT -169 -169
3% 3%
-
Net Profit -157 -157
33% 33%
-

In millions USD.

Don't miss a Thing! We will send you all news about Omeros Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Omeros Corporation Stock News

Neutral
Seeking Alpha
4 days ago
Omeros Corporation (NASDAQ:OMER ) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET Company Participants Jennifer Williams - Investor and Media relations, Cook Williams Communications, Inc. Gregory Demopulos - Chairman & CEO David Borges - Chief Accounting Officer Catherine Melfi - Chief Regulatory Officer Nadia Dac - Chief Commercial Officer Steven Whitaker - VP, Clinical Development ...
Neutral
Business Wire
4 days ago
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the fourth quarter and year ended December 31, 2024, which include: Net loss for the fourth quarter of 2024 was $31.4 million, or $0.54 per share, compared to a net loss of $32.2 million, or $0.56 per share for the third quarter of 2024. For the year en...
Neutral
Business Wire
10 days ago
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter and year ended December 31, 2024, on Monday, March 31, 2025, after the market closes. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results as well as r...
More Omeros Corporation News

Company Profile

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializes of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Head office United States
CEO Gregory Demopulos
Employees 202
Founded 1994
Website www.omeros.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today